25 XP   0   0   10

CONMED Corporation
Buy, Hold or Sell?

Let's analyse Conmed together

PenkeI guess you are interested in CONMED Corporation. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of CONMED Corporation. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about CONMED Corporation

I send you an email if I find something interesting about CONMED Corporation.

Quick analysis of Conmed (30 sec.)










What can you expect buying and holding a share of Conmed? (30 sec.)

How much money do you get?

How much money do you get?
$3.11
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
$26.44
Expected worth in 1 year
$35.36
How sure are you?
90.0%

+ What do you gain per year?

Total Gains per Share
$12.03
Return On Investment
18.3%

For what price can you sell your share?

Current Price per Share
$65.78
Expected price per share
$0 - $81.22
How sure are you?
50%

1. Valuation of Conmed (5 min.)




Live pricePrice per Share (EOD)

$65.78

Intrinsic Value Per Share

$18.14 - $44.57

Total Value Per Share

$44.58 - $71.01

2. Growth of Conmed (5 min.)




Is Conmed growing?

Current yearPrevious yearGrowGrow %
How rich?$834.2m$745.5m$88.6m10.6%

How much money is Conmed making?

Current yearPrevious yearGrowGrow %
Making money$64.4m-$80.5m$145m225.0%
Net Profit Margin5.2%-7.7%--

How much money comes from the company's main activities?

3. Financial Health of Conmed (5 min.)




4. Comparing to competitors in the Medical Devices industry (5 min.)




  Industry Rankings (Medical Devices)  


Richest
#40 / 334

Most Revenue
#44 / 334

Most Profit
#49 / 334

What can you expect buying and holding a share of Conmed? (5 min.)

Welcome investor! Conmed's management wants to use your money to grow the business. In return you get a share of Conmed.

What can you expect buying and holding a share of Conmed?

First you should know what it really means to hold a share of Conmed. And how you can make/lose money.

Speculation

The Price per Share of Conmed is $65.78. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Conmed.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Conmed, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $26.44. Based on the TTM, the Book Value Change Per Share is $2.23 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.17 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.78 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Conmed.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps2.043.1%2.043.1%-2.62-4.0%0.520.8%0.821.3%
Usd Book Value Change Per Share2.233.4%2.233.4%-0.17-0.3%0.991.5%0.681.0%
Usd Dividend Per Share0.781.2%0.781.2%0.781.2%0.751.1%0.741.1%
Usd Total Gains Per Share3.014.6%3.014.6%0.610.9%1.742.6%1.412.1%
Usd Price Per Share109.51-109.51-88.64-112.75-81.21-
Price to Earnings Ratio53.60-53.60--33.87-115.09-83.23-
Price-to-Total Gains Ratio36.42-36.42-145.12-91.95-19.54-
Price to Book Ratio4.14-4.14-3.66-4.67-3.58-
Price-to-Total Gains Ratio36.42-36.42-145.12-91.95-19.54-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share65.78
Number of shares15
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.780.75
Usd Book Value Change Per Share2.230.99
Usd Total Gains Per Share3.011.74
Gains per Quarter (15 shares)45.1026.06
Gains per Year (15 shares)180.40104.23
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
147134170455994
29326835090118198
3140401530135178302
4186535710180237406
5233669890225296510
62808031070270355614
73269371250315415718
837310701430360474822
941912041610405533926
10466133817904505921030

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%2.01.00.066.7%4.01.00.080.0%9.01.00.090.0%30.04.00.088.2%
Book Value Change Per Share1.00.00.0100.0%2.01.00.066.7%3.02.00.060.0%6.04.00.060.0%25.08.01.073.5%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%14.00.020.041.2%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%9.01.00.090.0%30.03.01.088.2%

Fundamentals of Conmed

About CONMED Corporation

CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as provides supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. It markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. The company also provides battery-powered and autoclavable bone power tool systems for use in orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries under Hall surgical brand name. In addition, it offers general surgery products, including clinical insufflation systems under AirSeal brand; smoke removal devices under Buffalo Filter brand; endomechanical products, such as tissue retrieval bags, trocars, suction irrigation devices, graspers, scissors, and dissectors used in minimally invasive surgeries; and electrosurgical solution comprising monopolar and bipolar generators, argon beam coagulation generators, handpieces, smoke management systems and other accessories. Further, the company provides endoscopic technologies, including therapeutic and diagnostic products for use in gastroenterology procedures, and products for the treatment of diseases of the dilatation, hemostasis, biliary, structure management, and infection prevention and patient monitoring, including ECG and EEG electrodes, and cardiac defibrillation pads. It markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida.

Fundamental data was last updated by Penke on 2024-04-13 10:05:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is just able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is fair priced.

1.1. Profitability of CONMED Corporation.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Conmed earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Conmed to the Medical Devices industry mean.
  • A Net Profit Margin of 5.2% means that $0.05 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of CONMED Corporation:

  • The MRQ is 5.2%. The company is making a profit. +1
  • The TTM is 5.2%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ5.2%TTM5.2%0.0%
TTM5.2%YOY-7.7%+12.9%
TTM5.2%5Y1.6%+3.6%
5Y1.6%10Y3.0%-1.4%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ5.2%-11.2%+16.4%
TTM5.2%-20.4%+25.6%
YOY-7.7%-13.4%+5.7%
5Y1.6%-21.0%+22.6%
10Y3.0%-24.9%+27.9%
1.1.2. Return on Assets

Shows how efficient Conmed is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Conmed to the Medical Devices industry mean.
  • 2.8% Return on Assets means that Conmed generated $0.03 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of CONMED Corporation:

  • The MRQ is 2.8%. Using its assets, the company is less efficient in making profit.
  • The TTM is 2.8%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ2.8%TTM2.8%0.0%
TTM2.8%YOY-3.5%+6.3%
TTM2.8%5Y1.0%+1.8%
5Y1.0%10Y1.9%-0.9%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ2.8%-4.0%+6.8%
TTM2.8%-4.7%+7.5%
YOY-3.5%-4.3%+0.8%
5Y1.0%-3.9%+4.9%
10Y1.9%-4.9%+6.8%
1.1.3. Return on Equity

Shows how efficient Conmed is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Conmed to the Medical Devices industry mean.
  • 7.7% Return on Equity means Conmed generated $0.08 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of CONMED Corporation:

  • The MRQ is 7.7%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 7.7%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ7.7%TTM7.7%0.0%
TTM7.7%YOY-10.8%+18.5%
TTM7.7%5Y2.1%+5.7%
5Y2.1%10Y3.8%-1.8%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ7.7%-4.1%+11.8%
TTM7.7%-5.7%+13.4%
YOY-10.8%-5.2%-5.6%
5Y2.1%-6.1%+8.2%
10Y3.8%-6.9%+10.7%

1.2. Operating Efficiency of CONMED Corporation.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Conmed is operating .

  • Measures how much profit Conmed makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Conmed to the Medical Devices industry mean.
  • An Operating Margin of 10.5% means the company generated $0.11  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of CONMED Corporation:

  • The MRQ is 10.5%. The company is operating less efficient.
  • The TTM is 10.5%. The company is operating less efficient.
Trends
Current periodCompared to+/- 
MRQ10.5%TTM10.5%0.0%
TTM10.5%YOY6.7%+3.8%
TTM10.5%5Y3.6%+6.9%
5Y3.6%10Y5.1%-1.5%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ10.5%-24.3%+34.8%
TTM10.5%-16.7%+27.2%
YOY6.7%-13.7%+20.4%
5Y3.6%-19.9%+23.5%
10Y5.1%-24.5%+29.6%
1.2.2. Operating Ratio

Measures how efficient Conmed is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Devices industry mean).
  • An Operation Ratio of 0.89 means that the operating costs are $0.89 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of CONMED Corporation:

  • The MRQ is 0.895. The company is less efficient in keeping operating costs low.
  • The TTM is 0.895. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ0.895TTM0.8950.000
TTM0.895YOY0.933-0.038
TTM0.8955Y0.917-0.022
5Y0.91710Y0.925-0.008
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8951.442-0.547
TTM0.8951.437-0.542
YOY0.9331.425-0.492
5Y0.9171.427-0.510
10Y0.9251.373-0.448

1.3. Liquidity of CONMED Corporation.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Conmed is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Devices industry mean).
  • A Current Ratio of 1.98 means the company has $1.98 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of CONMED Corporation:

  • The MRQ is 1.981. The company is able to pay all its short-term debts. +1
  • The TTM is 1.981. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.981TTM1.9810.000
TTM1.981YOY1.960+0.021
TTM1.9815Y2.117-0.136
5Y2.11710Y2.485-0.369
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.9812.691-0.710
TTM1.9812.724-0.743
YOY1.9603.496-1.536
5Y2.1173.619-1.502
10Y2.4853.487-1.002
1.3.2. Quick Ratio

Measures if Conmed is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Conmed to the Medical Devices industry mean.
  • A Quick Ratio of 0.86 means the company can pay off $0.86 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of CONMED Corporation:

  • The MRQ is 0.858. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.858. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.858TTM0.8580.000
TTM0.858YOY0.743+0.115
TTM0.8585Y0.972-0.114
5Y0.97210Y1.239-0.267
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8581.503-0.645
TTM0.8581.663-0.805
YOY0.7432.142-1.399
5Y0.9722.307-1.335
10Y1.2392.313-1.074

1.4. Solvency of CONMED Corporation.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Conmed assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Conmed to Medical Devices industry mean.
  • A Debt to Asset Ratio of 0.64 means that Conmed assets are financed with 63.7% credit (debt) and the remaining percentage (100% - 63.7%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of CONMED Corporation:

  • The MRQ is 0.637. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.637. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.637TTM0.6370.000
TTM0.637YOY0.676-0.038
TTM0.6375Y0.613+0.025
5Y0.61310Y0.562+0.050
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6370.402+0.235
TTM0.6370.390+0.247
YOY0.6760.335+0.341
5Y0.6130.442+0.171
10Y0.5620.460+0.102
1.4.2. Debt to Equity Ratio

Measures if Conmed is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Conmed to the Medical Devices industry mean.
  • A Debt to Equity ratio of 175.7% means that company has $1.76 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of CONMED Corporation:

  • The MRQ is 1.757. The company is just able to pay all its debts with equity.
  • The TTM is 1.757. The company is just able to pay all its debts with equity.
Trends
Current periodCompared to+/- 
MRQ1.757TTM1.7570.000
TTM1.757YOY2.082-0.325
TTM1.7575Y1.611+0.146
5Y1.61110Y1.335+0.276
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.7570.562+1.195
TTM1.7570.564+1.193
YOY2.0820.480+1.602
5Y1.6110.622+0.989
10Y1.3350.685+0.650

2. Market Valuation of CONMED Corporation

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Conmed generates.

  • Above 15 is considered overpriced but always compare Conmed to the Medical Devices industry mean.
  • A PE ratio of 53.60 means the investor is paying $53.60 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of CONMED Corporation:

  • The EOD is 32.195. Based on the earnings, the company is overpriced. -1
  • The MRQ is 53.597. Based on the earnings, the company is expensive. -2
  • The TTM is 53.597. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD32.195MRQ53.597-21.403
MRQ53.597TTM53.5970.000
TTM53.597YOY-33.870+87.467
TTM53.5975Y115.085-61.488
5Y115.08510Y83.232+31.853
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD32.195-1.055+33.250
MRQ53.597-1.715+55.312
TTM53.597-2.213+55.810
YOY-33.870-2.977-30.893
5Y115.085-2.300+117.385
10Y83.232-1.932+85.164
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of CONMED Corporation:

  • The EOD is 19.519. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The MRQ is 32.496. Based on how much money comes from the company's main activities, the company is fair priced.
  • The TTM is 32.496. Based on how much money comes from the company's main activities, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD19.519MRQ32.496-12.976
MRQ32.496TTM32.4960.000
TTM32.496YOY235.694-203.198
TTM32.4965Y85.626-53.130
5Y85.62610Y61.866+23.760
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD19.519-0.882+20.401
MRQ32.496-1.612+34.108
TTM32.496-3.213+35.709
YOY235.694-6.238+241.932
5Y85.626-5.513+91.139
10Y61.866-5.292+67.158
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Conmed is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Devices industry mean).
  • A PB ratio of 4.14 means the investor is paying $4.14 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of CONMED Corporation:

  • The EOD is 2.488. Based on the equity, the company is underpriced. +1
  • The MRQ is 4.141. Based on the equity, the company is fair priced.
  • The TTM is 4.141. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD2.488MRQ4.141-1.654
MRQ4.141TTM4.1410.000
TTM4.141YOY3.661+0.481
TTM4.1415Y4.665-0.524
5Y4.66510Y3.584+1.081
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD2.4882.025+0.463
MRQ4.1412.380+1.761
TTM4.1412.469+1.672
YOY3.6613.195+0.466
5Y4.6653.955+0.710
10Y3.5844.321-0.737
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of CONMED Corporation.

3.1. Institutions holding CONMED Corporation

Institutions are holding 119.073% of the shares of CONMED Corporation.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31BlackRock Inc16.34480.01415031016819581.656
2023-12-31Vanguard Group Inc11.11090.00823420011-20448-0.5943
2023-12-31Capital Research Global Investors8.95730.0743275710828999611.7545
2023-12-31Earnest Partners LLC7.62071.28262345697806053.5586
2023-12-31State Street Corporation3.85650.0063118705383420.7077
2023-12-31Bank of America Corp3.2220.0109991750-68950-6.5004
2023-12-31Ameriprise Financial Inc3.11460.0314958677-8494-0.8782
2023-12-31Champlain Investment Partners, LLC3.11020.6216957325140651.4911
2023-12-31Loomis, Sayles & Company LP2.63670.1361811601224612.8463
2023-12-31Macquarie Group Ltd2.42160.094374538717740.2386
2023-12-31Goldman Sachs Group Inc2.41150.0073742282385473108.0334
2023-12-31Dimensional Fund Advisors, Inc.2.31420.0228712332337944.9804
2023-12-31Geode Capital Management, LLC2.09330.0074644321309245.0414
2023-12-31SEI Investments Co1.9840.107461067713990329.7177
2023-12-31Wells Fargo & Co1.96770.0173605664-52862-8.0273
2023-12-31Principal Financial Group Inc1.95040.0419600334-13021-2.1229
2023-12-31Westwood Holdings Group Inc1.84760.525656869295351.7052
2023-12-31AXA SA1.81180.1969557691-66160-10.6051
2023-12-31ING Investment Management LLC1.59430.0643490730123162.5743
2023-12-31Barclays PLC1.45530.0184479356034015.5678
Total 81.82543.288725186283+941551+3.7%

3.2. Funds holding CONMED Corporation

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31American Funds SMALLCAP World A7.98950.3742245920026822812.2424
2024-03-28iShares Core S&P Small-Cap ETF6.74750.2072076918-7424-0.3562
2024-02-29Vanguard Total Stock Mkt Idx Inv3.11280.005958147-2744-0.2856
2024-02-29Champlain Small Company Fund, LLC3.06161.634294238512982015.9766
2024-02-29Vanguard Small Cap Index2.57480.045379253572580.9243
2024-03-28iShares Russell 2000 ETF2.44850.092275367642500.5671
2024-02-29Delaware Small Cap Core I2.14820.72146612148433614.6194
2023-12-31Macquarie US Small Cap Core Equity1.89660.855358379300
2024-03-31EARNEST Partners Smid Cap Core Founders1.66711.0905513154234164.7813
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr1.47410.03574537493590.0792
2024-02-29Vanguard Small Cap Growth Index Inv1.44170.102144377454991.2547
2023-12-31Harbor Small Cap Value Instl1.3742.2103422911-41844-9.0035
2023-12-31Champlain Small Company Adv1.2671.744390000-5000-1.2658
2023-12-31CT (Lux) Glb Smlr Coms IE1.02281.664731483839631.2748
2024-01-31Fidelity Small Cap Index1.00540.119330946151871.7047
2024-03-28iShares S&P Small-Cap 600 Growth ETF0.97660.407230060700
2023-12-31American Funds IS® Global Small Cap 10.96781.0244297908217687.883
2024-03-28SPDR® Portfolio S&P 600 Sm Cap ETF0.88450.20732722422800.103
2023-12-31UBS: US Equity Small Cap Growth0.87021.20452678554519720.2988
2024-03-28iShares Russell 2000 Growth ETF0.86460.1829266133-309-0.116
Total 43.795313.927513480500+542240+4.0%

3.3. Insider Transactions

Insiders are holding 0.539% of the shares of CONMED Corporation.

DateOwnerTypeAmountPricePost Transaction AmountLink
2023-12-04Stanley W Peters IiiSELL2300109.93
2023-11-07Stanley W Peters IiiSELL1200102.39
2023-09-13Stanley W Peters IiiSELL2000107.31
2023-08-16Todd W. GarnerSELL1355112
2023-06-15Curt R HartmanSELL1000136
2023-06-08John D FerrellSELL1700131.81
2023-06-08Stanley W Peters IiiSELL5000131.14
2023-06-07Brian ConcannonSELL812129.01
2023-05-22Stanley W Peters IiiSELL1500120.89
2023-05-01Brian ConcannonSELL2072125
2023-04-28Daniel S JonasSELL10000126.1
2023-04-28Johonna Marie PelletierSELL24017126.38
2023-04-28Peter K ShagorySELL2442128

4. Summary

4.1. Key Performance Indicators

The key performance indicators of CONMED Corporation compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--2.2302.2300%-0.167+108%0.987+126%0.675+230%
Book Value Per Share--26.44326.4430%24.213+9%24.227+9%21.989+20%
Current Ratio--1.9811.9810%1.960+1%2.117-6%2.485-20%
Debt To Asset Ratio--0.6370.6370%0.676-6%0.613+4%0.562+13%
Debt To Equity Ratio--1.7571.7570%2.082-16%1.611+9%1.335+32%
Dividend Per Share--0.7770.7770%0.7780%0.750+4%0.736+6%
Eps--2.0432.0430%-2.617+228%0.521+292%0.825+148%
Free Cash Flow Per Share--3.3703.3700%0.376+796%2.173+55%1.792+88%
Free Cash Flow To Equity Per Share---0.130-0.1300%7.683-102%3.920-103%2.798-105%
Gross Profit Margin--1.0001.0000%1.0000%-6.856+786%-2.928+393%
Intrinsic Value_10Y_max--44.566--------
Intrinsic Value_10Y_min--18.142--------
Intrinsic Value_1Y_max--2.735--------
Intrinsic Value_1Y_min--1.817--------
Intrinsic Value_3Y_max--9.536--------
Intrinsic Value_3Y_min--5.492--------
Intrinsic Value_5Y_max--17.928--------
Intrinsic Value_5Y_min--9.176--------
Market Cap2025445136.000-71%3454821480.0003454821480.0000%2729331968.000+27%3528617580.800-2%2529008242.400+37%
Net Profit Margin--0.0520.0520%-0.077+248%0.016+234%0.030+73%
Operating Margin--0.1050.1050%0.067+57%0.036+192%0.051+106%
Operating Ratio--0.8950.8950%0.933-4%0.917-2%0.925-3%
Pb Ratio2.488-66%4.1414.1410%3.661+13%4.665-11%3.584+16%
Pe Ratio32.195-66%53.59753.5970%-33.870+163%115.085-53%83.232-36%
Price Per Share65.780-66%109.510109.5100%88.640+24%112.748-3%81.209+35%
Price To Free Cash Flow Ratio19.519-66%32.49632.4960%235.694-86%85.626-62%61.866-47%
Price To Total Gains Ratio21.878-66%36.42236.4220%145.123-75%91.948-60%19.536+86%
Quick Ratio--0.8580.8580%0.743+15%0.972-12%1.239-31%
Return On Assets--0.0280.0280%-0.035+225%0.010+181%0.019+49%
Return On Equity--0.0770.0770%-0.108+240%0.021+277%0.038+101%
Total Gains Per Share--3.0073.0070%0.611+392%1.737+73%1.411+113%
Usd Book Value--834222000.000834222000.0000%745545000.000+12%756941400.000+10%682535600.000+22%
Usd Book Value Change Per Share--2.2302.2300%-0.167+108%0.987+126%0.675+230%
Usd Book Value Per Share--26.44326.4430%24.213+9%24.227+9%21.989+20%
Usd Dividend Per Share--0.7770.7770%0.7780%0.750+4%0.736+6%
Usd Eps--2.0432.0430%-2.617+228%0.521+292%0.825+148%
Usd Free Cash Flow--106316000.000106316000.0000%11580000.000+818%68277000.000+56%55859600.000+90%
Usd Free Cash Flow Per Share--3.3703.3700%0.376+796%2.173+55%1.792+88%
Usd Free Cash Flow To Equity Per Share---0.130-0.1300%7.683-102%3.920-103%2.798-105%
Usd Market Cap2025445136.000-71%3454821480.0003454821480.0000%2729331968.000+27%3528617580.800-2%2529008242.400+37%
Usd Price Per Share65.780-66%109.510109.5100%88.640+24%112.748-3%81.209+35%
Usd Profit--64459000.00064459000.0000%-80582000.000+225%16911200.000+281%25825100.000+150%
Usd Revenue--1240954000.0001240954000.0000%1045472000.000+19%1022923400.000+21%898779800.000+38%
Usd Total Gains Per Share--3.0073.0070%0.611+392%1.737+73%1.411+113%
 EOD+4 -4MRQTTM+0 -0YOY+27 -85Y+26 -1010Y+28 -8

4.2. Fundamental Score

Let's check the fundamental score of CONMED Corporation based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1532.195
Price to Book Ratio (EOD)Between0-12.488
Net Profit Margin (MRQ)Greater than00.052
Operating Margin (MRQ)Greater than00.105
Quick Ratio (MRQ)Greater than10.858
Current Ratio (MRQ)Greater than11.981
Debt to Asset Ratio (MRQ)Less than10.637
Debt to Equity Ratio (MRQ)Less than11.757
Return on Equity (MRQ)Greater than0.150.077
Return on Assets (MRQ)Greater than0.050.028
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of CONMED Corporation based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5033.091
Ma 20Greater thanMa 5074.509
Ma 50Greater thanMa 10078.134
Ma 100Greater thanMa 20090.305
OpenGreater thanClose62.280
Total0/5 (0.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets2,300,021
Total Liabilities1,465,799
Total Stockholder Equity834,222
 As reported
Total Liabilities 1,465,799
Total Stockholder Equity+ 834,222
Total Assets = 2,300,021

Assets

Total Assets2,300,021
Total Current Assets615,649
Long-term Assets1,684,372
Total Current Assets
Cash And Cash Equivalents 24,296
Net Receivables 242,279
Inventory 318,324
Other Current Assets 30,750
Total Current Assets  (as reported)615,649
Total Current Assets  (calculated)615,649
+/-0
Long-term Assets
Property Plant Equipment 137,328
Goodwill 806,844
Intangible Assets 649,484
Long-term Assets Other 79,505
Long-term Assets  (as reported)1,684,372
Long-term Assets  (calculated)1,673,161
+/- 11,211

Liabilities & Shareholders' Equity

Total Current Liabilities310,729
Long-term Liabilities1,155,070
Total Stockholder Equity834,222
Total Current Liabilities
Short-term Debt 8,217
Short Long Term Debt 708
Accounts payable 88,224
Other Current Liabilities 208,135
Total Current Liabilities  (as reported)310,729
Total Current Liabilities  (calculated)305,284
+/- 5,445
Long-term Liabilities
Long term Debt 973,140
Long-term Liabilities Other 121,028
Long-term Liabilities  (as reported)1,155,070
Long-term Liabilities  (calculated)1,094,168
+/- 60,902
Total Stockholder Equity
Common Stock313
Retained Earnings 452,531
Accumulated Other Comprehensive Income -50,170
Other Stockholders Equity 431,548
Total Stockholder Equity (as reported)834,222
Total Stockholder Equity (calculated)834,222
+/-0
Other
Capital Stock313
Cash and Short Term Investments 24,296
Common Stock Shares Outstanding 31,548
Current Deferred Revenue6,153
Liabilities and Stockholders Equity 2,300,021
Net Debt 966,958
Net Invested Capital 1,808,070
Net Working Capital 304,920
Property Plant and Equipment Gross 412,884
Short Long Term Debt Total 991,254



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-312000-12-311999-12-311998-12-311997-12-311996-12-311995-12-311994-12-311993-12-311992-12-311991-12-311990-12-311989-12-311988-12-311987-12-311986-12-31
> Total Assets 
6,400
13,000
13,500
21,900
22,200
38,300
41,900
57,300
62,100
62,100
170,100
561,600
628,800
662,200
679,571
701,608
742,140
805,058
872,825
903,783
861,571
893,951
931,661
957,503
985,773
935,594
1,084,462
1,090,508
1,098,194
1,112,944
1,328,983
1,357,961
1,369,138
1,775,095
1,751,673
1,766,017
2,297,592
2,300,021
2,300,0212,297,5921,766,0171,751,6731,775,0951,369,1381,357,9611,328,9831,112,9441,098,1941,090,5081,084,462935,594985,773957,503931,661893,951861,571903,783872,825805,058742,140701,608679,571662,200628,800561,600170,10062,10062,10057,30041,90038,30022,20021,90013,50013,0006,400
   > Total Current Assets 
3,900
9,600
8,900
12,300
11,200
25,200
25,700
24,300
28,300
28,300
71,800
121,900
159,600
176,700
192,031
164,549
193,666
201,106
222,942
255,515
249,883
279,022
294,262
324,700
350,192
356,724
346,187
372,132
381,150
404,392
330,512
356,783
374,351
397,363
416,654
460,123
581,226
615,649
615,649581,226460,123416,654397,363374,351356,783330,512404,392381,150372,132346,187356,724350,192324,700294,262279,022249,883255,515222,942201,106193,666164,549192,031176,700159,600121,90071,80028,30028,30024,30025,70025,20011,20012,3008,9009,6003,900
       Cash And Cash Equivalents 
300
4,600
2,700
300
200
4,500
7,600
2,000
3,600
3,600
20,200
13,500
5,900
3,700
3,470
1,402
5,626
5,986
4,189
3,454
3,831
11,695
11,811
9,188
12,417
26,048
23,720
54,443
66,332
72,504
27,428
32,622
17,511
25,856
27,356
20,847
28,942
24,296
24,29628,94220,84727,35625,85617,51132,62227,42872,50466,33254,44323,72026,04812,4179,18811,81111,6953,8313,4544,1895,9865,6261,4023,4703,7005,90013,50020,2003,6003,6002,0007,6004,5002003002,7004,600300
       Net Receivables 
1,700
2,500
2,400
5,100
6,400
9,000
8,600
11,500
13,100
13,100
27,100
47,400
66,800
76,400
78,626
51,188
58,093
60,449
74,593
83,327
75,120
82,067
96,515
126,162
145,350
135,641
139,315
144,231
129,870
133,863
148,244
167,037
181,550
189,097
177,152
183,882
191,345
242,279
242,279191,345183,882177,152189,097181,550167,037148,244133,863129,870144,231139,315135,641145,350126,16296,51582,06775,12083,32774,59360,44958,09351,18878,62676,40066,80047,40027,10013,10013,10011,5008,6009,0006,4005,1002,4002,5001,700
       Inventory 
1,800
2,300
3,600
5,800
4,300
7,000
9,000
9,000
9,600
9,600
23,200
57,900
78,100
89,700
104,612
107,390
120,443
120,945
127,935
152,428
151,687
164,969
159,976
164,275
172,796
168,438
156,228
143,211
148,149
166,894
135,869
141,436
154,599
164,616
194,868
231,644
332,320
318,324
318,324332,320231,644194,868164,616154,599141,436135,869166,894148,149143,211156,228168,438172,796164,275159,976164,969151,687152,428127,935120,945120,443107,390104,61289,70078,10057,90023,2009,6009,6009,0009,0007,0004,3005,8003,6002,3001,800
       Other Current Assets 
100
200
200
1,100
300
4,700
500
1,800
0
2,000
1,300
3,100
8,800
6,900
5,323
4,569
9,504
13,726
16,225
16,306
4,033
20,291
25,960
10,293
11,153
16,314
14,993
17,045
22,451
31,131
18,971
15,688
20,691
17,794
17,278
23,750
28,619
30,750
30,75028,61923,75017,27817,79420,69115,68818,97131,13122,45117,04514,99316,31411,15310,29325,96020,2914,03316,30616,22513,7269,5044,5695,3236,9008,8003,1001,3002,00001,8005004,7003001,100200200100
   > Long-term Assets 
2,500
3,400
4,600
9,600
11,000
13,100
16,200
33,000
0
33,800
98,300
439,700
469,200
485,500
487,540
537,059
548,474
603,952
649,883
648,268
611,688
614,929
637,399
632,803
635,581
578,870
738,275
718,376
717,044
708,552
998,471
1,001,178
994,787
1,377,732
1,335,019
1,305,894
1,716,366
1,684,372
1,684,3721,716,3661,305,8941,335,0191,377,732994,7871,001,178998,471708,552717,044718,376738,275578,870635,581632,803637,399614,929611,688648,268649,883603,952548,474537,059487,540485,500469,200439,70098,30033,800033,00016,20013,10011,0009,6004,6003,4002,500
       Property Plant Equipment 
2,400
3,300
4,300
5,900
8,000
8,700
12,100
16,400
16,200
16,200
26,500
59,400
60,800
57,800
62,450
91,026
95,608
97,383
101,465
104,224
116,480
123,679
143,737
143,502
140,895
139,187
139,041
138,985
133,429
128,547
122,029
116,229
113,245
118,883
111,407
108,863
115,611
137,328
137,328115,611108,863111,407118,883113,245116,229122,029128,547133,429138,985139,041139,187140,895143,502143,737123,679116,480104,224101,46597,38395,60891,02662,45057,80060,80059,40026,50016,20016,20016,40012,1008,7008,0005,9004,3003,3002,400
       Goodwill 
0
0
0
0
0
0
0
0
0
41,400
70,600
369,500
404,400
427,600
420,809
440,892
442,665
484,531
529,717
335,651
290,512
289,508
290,245
290,505
295,068
234,815
256,821
248,428
256,232
260,651
397,664
401,954
400,440
618,042
618,440
617,528
815,429
806,844
806,844815,429617,528618,440618,042400,440401,954397,664260,651256,232248,428256,821234,815295,068290,505290,245289,508290,512335,651529,717484,531442,665440,892420,809427,600404,400369,50070,60041,400000000000
       Intangible Assets 
0
0
0
3,300
2,900
3,400
3,400
14,500
17,600
17,600
70,600
369,500
404,400
427,600
420,809
440,892
442,665
484,531
529,717
527,053
191,135
191,807
195,939
190,849
190,091
195,531
190,809
319,440
316,440
308,171
419,549
414,940
413,193
532,800
501,537
471,049
681,799
649,484
649,484681,799471,049501,537532,800413,193414,940419,549308,171316,440319,440190,809195,531190,091190,849195,939191,807191,135527,053529,717484,531442,665440,892420,809427,600404,400369,50070,60017,60017,60014,5003,4003,4002,9003,300000
       Long-term Assets Other 
100
100
300
400
100
1,000
700
2,100
0
4,100
1,200
10,800
4,000
100
4,281
5,141
10,201
22,038
18,701
16,991
13,561
9,935
7,478
5,994
7,518
6,948
150,547
10,340
9,545
11,183
59,229
63,334
62,747
102,348
96,793
98,797
93,877
79,505
79,50593,87798,79796,793102,34862,74763,33459,22911,1839,54510,340150,5476,9487,5185,9947,4789,93513,56116,99118,70122,03810,2015,1414,2811004,00010,8001,2004,10002,1007001,000100400300100100
       Deferred Long Term Asset Charges 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,389
1,057
1,183
1,398
1,332
3,712
4,721
0
0
0
0
0
0
0000004,7213,7121,3321,3981,1831,0572,3890000000000000000000000000
> Total Liabilities 
2,500
2,900
2,600
11,600
9,400
4,300
3,200
19,800
19,000
19,000
11,500
398,900
446,600
450,900
448,968
417,974
355,201
371,568
424,842
450,777
421,217
388,949
399,927
380,988
399,210
362,523
477,464
484,189
516,896
527,871
748,407
726,529
706,868
1,064,628
1,042,635
980,582
1,552,047
1,465,799
1,465,7991,552,047980,5821,042,6351,064,628706,868726,529748,407527,871516,896484,189477,464362,523399,210380,988399,927388,949421,217450,777424,842371,568355,201417,974448,968450,900446,600398,90011,50019,00019,00019,8003,2004,3009,40011,6002,6002,9002,500
   > Total Current Liabilities 
1,300
1,800
1,400
4,700
3,300
3,100
1,900
8,900
10,200
10,200
5,800
30,600
66,200
67,200
78,276
119,837
57,974
54,855
63,061
62,132
75,205
77,284
74,914
78,197
179,866
131,184
122,508
111,265
115,956
119,718
113,952
150,003
160,944
188,087
190,201
196,646
296,552
310,729
310,729296,552196,646190,201188,087160,944150,003113,952119,718115,956111,265122,508131,184179,86678,19774,91477,28475,20562,13263,06154,85557,974119,83778,27667,20066,20030,6005,80010,20010,2008,9001,9003,1003,3004,7001,4001,8001,300
       Short-term Debt 
100
600
100
2,000
500
100
100
2,500
2,500
2,500
0
11,000
23,000
32,900
36,068
73,429
2,631
4,143
4,037
4,208
3,148
3,349
3,185
2,174
110,433
54,557
1,050
1,140
1,234
1,339
10,202
14,699
18,336
13,596
25,884
12,249
69,746
8,217
8,21769,74612,24925,88413,59618,33614,69910,2021,3391,2341,1401,05054,557110,4332,1743,1853,3493,1484,2084,0374,1432,63173,42936,06832,90023,00011,00002,5002,5002,5001001005002,000100600100
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,234
1,339
10,202
14,699
18,336
13,596
18,218
12,249
69,746
708
70869,74612,24918,21813,59618,33614,69910,2021,3391,2340000000000000000000000000000
       Accounts payable 
0
0
0
0
1,100
1,100
700
1,300
0
1,500
2,400
9,600
19,600
16,500
20,350
19,877
22,074
18,320
28,913
31,084
41,823
38,987
35,887
26,210
21,692
21,162
23,622
27,448
23,752
34,720
41,647
42,044
53,498
55,968
53,310
58,197
73,393
88,224
88,22473,39358,19753,31055,96853,49842,04441,64734,72023,75227,44823,62221,16221,69226,21035,88738,98741,82331,08428,91318,32022,07419,87720,35016,50019,6009,6002,4001,50001,3007001,1001,1000000
       Other Current Liabilities 
1,200
1,200
1,300
2,700
1,700
1,900
1,100
5,100
0
6,200
3,400
10,000
23,600
17,800
21,858
26,531
19,012
21,427
16,708
13,284
11,795
14,529
14,434
76,023
69,433
76,627
121,458
110,125
114,722
48,933
30,067
59,002
46,186
64,833
60,836
65,712
143,763
208,135
208,135143,76365,71260,83664,83346,18659,00230,06748,933114,722110,125121,45876,62769,43376,02314,43414,52911,79513,28416,70821,42719,01226,53121,85817,80023,60010,0003,4006,20005,1001,1001,9001,7002,7001,3001,2001,200
   > Long-term Liabilities 
1,200
1,100
1,200
6,900
6,100
1,200
1,300
10,900
0
8,800
5,700
368,300
380,400
383,700
370,692
298,137
297,227
316,713
361,781
388,645
346,012
311,665
325,013
302,791
219,344
231,339
354,956
372,924
400,940
408,153
634,455
576,526
545,924
876,541
852,434
783,936
1,255,495
1,155,070
1,155,0701,255,495783,936852,434876,541545,924576,526634,455408,153400,940372,924354,956231,339219,344302,791325,013311,665346,012388,645361,781316,713297,227298,137370,692383,700380,400368,3005,7008,800010,9001,3001,2006,1006,9001,2001,1001,200
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
88,952
160,802
214,435
240,201
269,471
488,288
471,744
438,564
755,211
735,221
672,407
985,076
0
0985,076672,407735,221755,211438,564471,744488,288269,471240,201214,435160,80288,9520000000000000000000000000
       Deferred Long Term Asset Charges 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,389
1,057
1,183
1,398
1,332
3,712
4,721
0
0
0
0
0
0
0000004,7213,7121,3321,3981,1831,0572,3890000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
15,858
16,982
14,025
10,122
19,863
23,448
30,332
20,992
45,325
22,680
28,116
49,602
86,636
45,290
48,516
127,438
146,167
104,782
107,360
104,234
102,457
98,803
258,660
0
0258,66098,803102,457104,234107,360104,782146,167127,43848,51645,29086,63649,60228,11622,68045,32520,99230,33223,44819,86310,12214,02516,98215,85800000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
92,785
107,518
113,199
112,223
114,623
119,143
77,668
81,061
74,488
57,875
68,537
66,725
0
066,72568,53757,87574,48881,06177,668119,143114,623112,223113,199107,51892,7850000000000000000000000000
> Total Stockholder Equity
3,900
10,100
10,900
10,300
12,800
34,000
38,700
37,500
0
43,100
158,600
162,700
182,200
211,300
230,603
283,634
386,939
433,490
447,983
453,006
440,354
505,002
531,734
576,515
586,563
573,071
606,998
606,319
581,298
585,073
580,576
631,432
662,270
710,467
709,038
785,435
745,545
834,222
834,222745,545785,435709,038710,467662,270631,432580,576585,073581,298606,319606,998573,071586,563576,515531,734505,002440,354453,006447,983433,490386,939283,634230,603211,300182,200162,700158,60043,100037,50038,70034,00012,80010,30010,90010,1003,900
   Common Stock
0
0
0
0
0
0
0
0
0
100
0
0
0
200
153
253
288
291
301
311
313
313
313
263,550
248,404
244,980
256,672
228,002
214,975
313
313
313
313
313
313
313
313
313
313313313313313313313313313214,975228,002256,672244,980248,404263,550313313313311301291288253153200000100000000000
   Retained Earnings 
3,700
4,800
5,600
5,000
7,400
11,400
15,500
14,100
19,500
19,500
46,600
39,600
57,400
84,500
103,834
128,240
162,391
194,473
227,938
259,932
247,425
284,850
327,471
325,370
354,020
354,439
377,907
395,889
406,145
414,506
406,932
440,085
464,851
470,844
457,417
496,605
412,631
452,531
452,531412,631496,605457,417470,844464,851440,085406,932414,506406,145395,889377,907354,439354,020325,370327,471284,850247,425259,932227,938194,473162,391128,240103,83484,50057,40039,60046,60019,50019,50014,10015,50011,4007,4005,0005,6004,8003,700
   Accumulated Other Comprehensive Income 
-1,700
-2,100
-2,800
-5,000
-5,800
-7,100
-8,600
-10,200
-12,100
-12,100
-17,400
-21,300
-29,400
-400
-1,027
-5,197
-7,153
2,069
-6,399
-9,736
-8,612
-505
-31,032
-12,405
-15,861
-26,348
-27,581
-17,572
-39,822
-53,894
-58,526
-49,078
-55,737
-59,277
-63,681
-54,203
-57,858
-50,170
-50,170-57,858-54,203-63,681-59,277-55,737-49,078-58,526-53,894-39,822-17,572-27,581-26,348-15,861-12,405-31,032-505-8,612-9,736-6,3992,069-7,153-5,197-1,027-400-29,400-21,300-17,400-12,100-12,100-10,200-8,600-7,100-5,800-5,000-2,800-2,100-1,700
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
321,994
324,322
326,436
319,752
324,915
329,276
333,795
341,738
379,324
382,628
396,771
413,235
0
0413,235396,771382,628379,324341,738333,795329,276324,915319,752326,436324,322321,9940000000000000000000000000
   Treasury Stock0-22,776-54,051-67,639-80,737-88,895-93,683-97,419-100,767-105,090-98,747-67,963-77,327-71,315-54,129-57,269-67,582-83,630-75,782-30,408-419-419-419-41900000000000000
   Other Stockholders Equity 
1,900
7,400
8,100
10,300
11,200
29,700
31,800
33,600
0
35,700
129,400
144,400
154,200
127,000
127,643
160,338
231,413
236,657
226,143
202,499
201,228
220,344
234,982
263,237
248,091
244,667
256,359
227,689
214,662
224,148
231,857
240,112
252,843
298,587
314,989
342,720
390,459
431,548
431,548390,459342,720314,989298,587252,843240,112231,857224,148214,662227,689256,359244,667248,091263,237234,982220,344201,228202,499226,143236,657231,413160,338127,643127,000154,200144,400129,40035,700033,60031,80029,70011,20010,3008,1007,4001,900



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue1,240,954
Cost of Revenue-597,887
Gross Profit643,067643,067
 
Operating Income (+$)
Gross Profit643,067
Operating Expense-512,281
Operating Income130,786130,786
 
Operating Expense (+$)
Research Development52,602
Selling General Administrative505,817
Selling And Marketing Expenses0
Operating Expense512,281558,419
 
Net Interest Income (+$)
Interest Income0
Interest Expense-39,775
Other Finance Cost-61
Net Interest Income-39,714
 
Pretax Income (+$)
Operating Income130,786
Net Interest Income-39,714
Other Non-Operating Income Expenses0
Income Before Tax (EBT)80,828180,744
EBIT - interestExpense = 91,011
80,828
104,234
Interest Expense39,775
Earnings Before Interest and Taxes (EBIT)130,786120,603
Earnings Before Interest and Taxes (EBITDA)182,186
 
After tax Income (+$)
Income Before Tax80,828
Tax Provision--28,365
Net Income From Continuing Ops57,972109,193
Net Income64,459
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses1,110,168
Total Other Income/Expenses Net-49,95839,714
 

Technical Analysis of Conmed
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Conmed. The general trend of Conmed is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Conmed's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of CONMED Corporation.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 70.26 < 80.65 < 81.22.

The bearish price targets are: .

Tweet this
CONMED Corporation Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of CONMED Corporation. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

CONMED Corporation Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of CONMED Corporation. The current macd is -3.46478038.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Conmed price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Conmed. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Conmed price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
CONMED Corporation Daily Moving Average Convergence/Divergence (MACD) ChartCONMED Corporation Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of CONMED Corporation. The current adx is 30.32.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Conmed shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.
CONMED Corporation Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of CONMED Corporation. The current sar is 75.96.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
CONMED Corporation Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of CONMED Corporation. The current rsi is 33.09. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
CONMED Corporation Daily Relative Strength Index (RSI) ChartCONMED Corporation Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of CONMED Corporation. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Conmed price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
CONMED Corporation Daily Stochastic Oscillator ChartCONMED Corporation Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of CONMED Corporation. The current cci is -181.75042218.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
CONMED Corporation Daily Commodity Channel Index (CCI) ChartCONMED Corporation Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of CONMED Corporation. The current cmo is -35.06173092.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
CONMED Corporation Daily Chande Momentum Oscillator (CMO) ChartCONMED Corporation Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of CONMED Corporation. The current willr is -75.86734694.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Conmed is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
CONMED Corporation Daily Williams %R ChartCONMED Corporation Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of CONMED Corporation.

CONMED Corporation Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of CONMED Corporation. The current atr is 2.87262265.

CONMED Corporation Daily Average True Range (ATR) ChartCONMED Corporation Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of CONMED Corporation. The current obv is -4,868,102.

CONMED Corporation Daily On-Balance Volume (OBV) ChartCONMED Corporation Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of CONMED Corporation. The current mfi is 33.30.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
CONMED Corporation Daily Money Flow Index (MFI) ChartCONMED Corporation Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for CONMED Corporation.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-05STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-06MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-07STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-11STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-13STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-15STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-19CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-20SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-22CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-27STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-29CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-02DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-03CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-05CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-08STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-09DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-01-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-16DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-18SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-22WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-24ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-29RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-01STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-08RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-02-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-14WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-16STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-04ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-05SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-06WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-13STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-14SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-15CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-25RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-03-27MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-28SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-04-01STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-03STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-09DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-10DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-04-11STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-12SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-16ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-17MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-23STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-25BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-26RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).

6.3. Candlestick Patterns

CONMED Corporation Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of CONMED Corporation based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5033.091
Ma 20Greater thanMa 5074.509
Ma 50Greater thanMa 10078.134
Ma 100Greater thanMa 20090.305
OpenGreater thanClose62.280
Total0/5 (0.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Conmed with someone you think should read this too:
  • Are you bullish or bearish on Conmed? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Conmed? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about CONMED Corporation

I send you an email if I find something interesting about CONMED Corporation.


Comments

How you think about this?

Leave a comment

Stay informed about CONMED Corporation.

Receive notifications about CONMED Corporation in your mailbox!